NasdaqCM - Nasdaq Real Time Price USD

BeyondSpring Inc. (BYSI)

1.6800
-0.1000
(-5.62%)
At close: May 9 at 4:00:02 PM EDT
1.6200
-0.06
(-3.57%)
After hours: May 9 at 7:20:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
1,351
1,351
Operating Expense
8,754
8,754
15,081
38,590
67,591
Operating Income
-8,754
-8,754
-15,081
-37,239
-66,240
Net Non Operating Interest Income Expense
59
59
322
178
11
Other Income Expense
-74
-74
836
944
1,591
Pretax Income
-8,769
-8,769
-13,923
-36,117
-64,638
Tax Provision
96
96
92
163
3,570
Net Income Common Stockholders
-11,123
-11,123
-21,026
-33,279
-64,179
Diluted NI Available to Com Stockholders
-11,123
-11,123
-21,026
-33,279
-64,179
Basic EPS
-0.28
--
-0.54
-0.85
-1.64
Diluted EPS
-0.28
--
-0.54
-0.85
-1.64
Basic Average Shares
39,733.1910
--
38,996.4630
39,093.2460
39,023.6430
Diluted Average Shares
39,733.1910
--
38,996.4630
39,093.2460
39,023.6430
Total Operating Income as Reported
-8,754
-8,754
-15,081
-37,239
-66,240
Total Expenses
8,754
8,754
15,081
38,590
67,591
Net Income from Continuing & Discontinued Operation
-11,123
-11,123
-21,026
-33,279
-64,179
Normalized Income
-3,219.1600
-3,219.1600
-12,991.8800
-32,940.0900
-64,347.6300
Interest Income
59
59
322
195
98
Interest Expense
--
--
0
17
87
Net Interest Income
59
59
322
178
11
EBIT
-8,754
-8,754
-15,081
-36,100
-64,551
EBITDA
-8,469
-8,469
-14,779
-35,868
-64,490
Reconciled Depreciation
285
285
302
232
61
Net Income from Continuing Operation Net Minority Interest
-3,295
-3,295
-13,093
-33,279
-64,179
Total Unusual Items Excluding Goodwill
-96
-96
-128
-429
231
Total Unusual Items
-96
-96
-128
-429
231
Normalized EBITDA
-8,373
-8,373
-14,651
-35,439
-64,721
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-20.1600
-20.1600
-26.8800
-90.0900
62.3700
12/31/2021 - 3/9/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

JBIO Jade Biosciences, Inc.
8.65
-3.89%
 
FULC Fulcrum Therapeutics, Inc.
5.37
-0.74%
 
TLSA Tiziana Life Sciences Ltd
1.5700
+3.97%
 
SILO Silo Pharma, Inc.
0.8149
0.00%
 
CHRS Coherus BioSciences, Inc.
0.9687
-2.38%
 
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
 
GLUE Monte Rosa Therapeutics, Inc.
4.0900
-3.08%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8197
+0.27%
 
PYPD PolyPid Ltd.
2.7700
-0.72%
 
NTHI NeOnc Technologies Holdings, Inc.
7.34
+11.21%